Quarterly report pursuant to Section 13 or 15(d)

Equity and Equity Compensation Plans - Schedule of Stock Option Activity (Details)

v3.22.2
Equity and Equity Compensation Plans - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 01, 2019
Jun. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Number of Options        
Outstanding, beginning balance (in shares)     4,019,011  
PSOs earned (in shares)   150,000    
Options exercised (in shares)     (645,120)  
Options canceled (in shares)     (10,290)  
Outstanding, ending balance (in shares)   3,513,601 3,513,601 4,019,011
Options exercisable at period end (in shares)   3,513,601 3,513,601  
Weighted-Average Exercise Price        
Outstanding, beginning balance (in dollars per share)     $ 8.02  
PSOs earned (in dollars per share)     27.50  
Options exercised (in dollars per share)     6.97  
Options canceled (in dollars per share)     6.55  
Outstanding, ending balance (in dollars per share)   $ 9.05 9.05 $ 8.02
Options exercisable at period end (in dollars per share)   $ 9.05 $ 9.05  
Weighted-Average Remaining Contractual Life (Years)        
Weighted average remaining contractual life outstanding     3 years 3 months 18 days 3 years 8 months 23 days
Weighted average remaining contractual life exercisable     3 years 3 months 18 days  
Aggregate Intrinsic Value        
Options outstanding, Aggregate intrinsic value   $ 4,717 $ 4,717 $ 122,038
Options exercisable, Aggregate intrinsic value   $ 4,717 $ 4,717  
Chief Executive Officer | Performance Restricted Stock Units        
Aggregate Intrinsic Value        
Options granted (in shares) 150,000